Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Understanding the link between hormonal fluctuations and endothelial function across the menstrual cycle

FY 2023-24

Summary
Cardiovascular diseases are the leading cause of death worldwide. Unfortunately, there is a paucity in research regarding female physiology which limits our capacity to prevent and treat cardiovascular diseases in women. Another contributing factor which limits research in women is a lack of understanding and consensus on ways of standardizing cardiovascular testing in women. For example, the flow mediated dilation (FMD) test has been shown to effectively quantify endothelial function, a predictor of future CVD. However, menstrual cycle phase may impact the FMD response (%FMD), where increases in estrogen (E2), characteristic of the late follicular (LF) phase may increase %FMD. This suggests the importance of controlling for menstrual cycle phase when assessing a woman’s CVD risk using the FMD. However, recent FMD studies have been limited by menstrual cycle tracking methodologies which do not allow for the assessment of %FMD on the day of LF associated with peak E2. To resolve this, the purpose of this study is to compare %FMD between EF and LF phases where the LF time point is defined as the day of peak E2 in young, naturally cycling women. We hypothesize that with proper identification of the LF E2 surge there will be a greater %FMD response in LF than EF, whereas traditional means of identifying LF will result in non-significant differences in %FMD between LF and EF. The real-time tracking of E2 via the Mira urinary hormone monitoring device, which has been developed as a fertility tool has the potential to resolve difficulties with menstrual cycle tracking in cardiovascular research studies. Thus, the findings of this study may improve the ability of cardiovascular research labs to study women and develop sex-specific approaches to prevent and treat CVD.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
505963
Name
Delage Shannon I
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Understanding the link between hormonal fluctuations and endothelial function across the menstrual cycle
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiovascular Diseases; Endothelial Dysfunction; Endothelial Function; Estrogen; Flow-Mediated Dilation; Inclusion Of Women In Research; Menstrual Cycle; Menstrual Cycle Tracking; Women'S Cardiovascular Health; Women'S Health
Abstract
Cardiovascular diseases are the leading cause of death worldwide. Unfortunately, there is a paucity in research regarding female physiology which limits our capacity to prevent and treat cardiovascular diseases in women. Another contributing factor which limits research in women is a lack of understanding and consensus on ways of standardizing cardiovascular testing in women. For example, the flow mediated dilation (FMD) test has been shown to effectively quantify endothelial function, a predictor of future CVD. However, menstrual cycle phase may impact the FMD response (%FMD), where increases in estrogen (E2), characteristic of the late follicular (LF) phase may increase %FMD. This suggests the importance of controlling for menstrual cycle phase when assessing a woman’s CVD risk using the FMD. However, recent FMD studies have been limited by menstrual cycle tracking methodologies which do not allow for the assessment of %FMD on the day of LF associated with peak E2. To resolve this, the purpose of this study is to compare %FMD between EF and LF phases where the LF time point is defined as the day of peak E2 in young, naturally cycling women. We hypothesize that with proper identification of the LF E2 surge there will be a greater %FMD response in LF than EF, whereas traditional means of identifying LF will result in non-significant differences in %FMD between LF and EF. The real-time tracking of E2 via the Mira urinary hormone monitoring device, which has been developed as a fertility tool has the potential to resolve difficulties with menstrual cycle tracking in cardiovascular research studies. Thus, the findings of this study may improve the ability of cardiovascular research labs to study women and develop sex-specific approaches to prevent and treat CVD.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Delage, Shannon I
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~